Product news

Share this article:

Abbott received FDA approval for its Xience V drug-coated stent, used to treat coronary artery disease. The stent is used to prop open a narrowed or blocked artery and releases a drug, everolimus, to prevent further blockage.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters